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Comparative Effectiveness of Topical
Drugs in Dermatologic Priority
Diseases: Geometry of Randomized
Trial Networks
Chante Karimkhani1 and Robert P. Dellavalle2,3,4
This commentary explores the fundamentals of network theory, a branch of
applied mathematics that has numerous applications in many fields. Maruani
et al. (2014) used network theory to analyze the geometry of the evidence base
for dermatologic treatments. This is a prime example of the innovative nature of
network theory: the mapping of a complex system into an abstract geometry for
easier analysis. The interpretation rests upon the two concepts of diversity and
co-occurrence. The mathematical foundation of these concepts is briefly
reviewed. In addition, examples of the application of network geometry in other
dermatologic settings as well as in science and technology are presented.
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Comparative effectiveness research (CER)
consists of rigorous and systematic
investigation into treatment modalities
for specific disease states. This critical
effort requires identifying areas lacking a
strong evidence base. As demonstrated
by Maruani et al. (2014), treatment
network analysis provides enlightened
guidance for future CER work. Network
analysis, a branch of applied mathe-
matics, represents graphic comparisons
of the various studied treatment
modalities for a specific condition
with graphs. The network comprises
nodes, representing specific treatments,
connected by edges. In general, indicat-
ing head-to-head trials, the overall
pattern of nodal connection produces a
geometrical representation to identify
appropriate data on which to make
evidence-based decisions. The evalua-
tion of trial networks rests upon two
concepts: diversity and co-occurrence.
Diversity
Diversity describes the geometry. This
can range from the extremes of a star-
shaped geometry with all lines emanat-
ing from a central common point, indi-
cating that the same comparator is used
in all trials, to a true polygonal shape in
which all nodes are interconnected. In
the paper by Maruani et al. (2014), the
network geometry for chronic lower
extremity wounds is most similar to the
star-shaped geometry, with all trials
involving comparisons with a placebo.
The network geometries for acne
vulgaris and psoriasis are less star-
shaped and more polygonal in shape,
although the predominance of relying
on a placebo remains apparent. Asym-
metry in the geometry raises the
possibility of bias. An important bias to
consider is comparator preference bias.
Why is a particular head-to-head com-
parison avoided? Are study investigators
afraid of inferiority? Do they use
‘‘straw man’’ comparators, known to
be inferior, in order to exaggerate the
treatment effectiveness? To measure
diversity mathematically, one may use
Hurlbert’s probability of interspecific
encounter (PIE), which is the pro-
bability that two randomly sampled
treatment groups from the network
have been allocated to two different
treatments (Salanti et al., 2008a). The
mathematical definition of PIE is given
by the equation





where pi is the proportion of each
treatment i, and T is the total number
of different treatments that appear N
times in the network (Salanti et al.,
2008a).
A network in which all treatments are
represented equally has a PIE¼1. As
asymmetry increases, PIE decreases. A
PIE value of less than 0.75 signifies
limited diversity. For the three dermato-
logic conditions studied by Maruani
et al. (2014), PIE values were greater
than 0.8 (psoriasis 0.88, chronic lower
extremity wounds 0.86, acne vulgaris
0.89), indicating considerable diversity.






Co-occurrence is an evaluation of the
tendency for treatment pairs to be com-
pared with each other (Salanti et al.,
2008b). Do these comparisons occur
more than would be expected by
chance? Luckily, there is another mathe-
matical value to provide objective eva-
luation of co-occurrence. An adaption of
the Stone and Roberts’ C-score index
yields checkerboard units (CUs). The
mathematical definition of CU is given by
CUAB ¼ ðQAQABÞðQB QABÞ
where A and B are two treatments that
appear QA and QB times in the network
and QAB is the number of studies directly
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comparing A and B (Salanti et al., 2008a).
The average of CUs for all possible
comparisons in a network yields the
C-score. A larger C-score implies a grea-
ter degree of co-occurrence, either predi-
lection or aversion, for particular head-to-
head comparisons. C-scores are interpre-
ted with statistical significance, with
Po0.05 considered significant. The three
trial networks studied by Maruani et al.
(2014) demonstrated no significant co-
occurrence.
Use in dermatology
Another example of the application of
network geometry in the field of derma-
tology is Kim et al.’s (2014) investigation
of treatment modalities for basal cell
carcinoma (BCC). Using a study design
similar to that used by Maruani et al.
(2014), three classes of interventions for
BCC were compared: surgical, destruc-
tive, and topical. Despite a plethora of
treatments for BCC, there was a sub-
stantial lack of head-to-head trials, with
almost exclusive use of placebos or
comparison of one agent against itself
(e.g., at a different dose). The geometric
pattern resembles those of chronic lower
extremity wounds in the paper by
Maruani et al. (2014), with multiple
lines emanating from a common
comparator. Destructive and surgical
treatments were rarely compared with
topical treatments.
Other applications
One of the foundational applications of
network theory was Leonard Euler’s
1736 proof regarding the seven bridges
of Konigsberg (modern day Prussia;
Pryor and Sleigh, 2011). Euler proved
the non-existence of what is now refer-
red to as a Euler path, a continuous path
passing to each node through each edge
once and only once. More importantly,
Euler’s proof set an example of solving a
real-world problem by distilling it into
an abstract topological graph. Network
theory has innumerable applications in
the modern day. In the basic sciences,
network theory is used to model
biological systems, such as transcription
factor circuitry and various metabolic
pathways (Baraba´si et al., 2011). It has
also been used widely in social sciences
to model social interactions between
groups and individuals. The World
Wide Web is the largest example of
network topology, with over one billion
nodes representing webpages and edges
representing hyperlinks or URLs (Albert
and Barabasi, 2002).
Conclusion
Network theory is a powerful tool that
provides visual representations of com-
plex structures. Maruani et al. (2014)
have applied this modality brilliantly to
dermatological treatments in an effort to
reduce research gaps identified by the
CER initiative. In an ideal world case,
head-to-head comparisons would be
performed when a multitude of health-
care interventions exist for a particular
disease. A strong evidence base best
informs treatment decisions for greatest
patient benefit. Network geometry is an
emerging model to accomplish this
method investigation and analysis.
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Diagnosis by Numbers: Defining Skin
Disease Pathogenesis through
Collated Gene Signatures
Amr Salam1 and John A. McGrath1
Disease gene expression profiles can be utilized as biomarkers for diagnostic,
prognostic, and targeted therapeutic purposes, although individual data sets may
be of limited generic value. To develop broader clinical relevance from disease
gene signatures, Inkeles et al. demonstrate how mining publically available
microarray data from a range of skin disorders can elucidate disease pathways,
generate a multi-disease classifier, and identify potential therapeutic targets. This
integrative molecular classification and functional analysis offers a new approach
to understanding disease pathogenesis, with significant implications for
diagnostics and the development of personalized medicine.
Journal of Investigative Dermatology (2015) 135, 17–19; doi:10.1038/jid.2014.389
DNA microarrays work on the principle
that complementary strands of nucleic
acid bind together, and the use of arrays
has proven invaluable through the ability
to examine expression of thousands of
genes simultaneously. It is now almost
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